Department of Health and Human Services
National Institutes of Health
Toggle navigation
Search
Home
About the Clinical Center
Clinical Trials & You
Participate in a Study
Referring a Patient
How to Search
Contact Us
Search the Studies
Browse by Institute
Searched Result
46
Studies found from all possible combinations of your search terms. Select a protocol that you wish to review.
Protocol Number
Title
Protocol Status
Min-Max Age
Institute
Keywords
000519-EI
Phase II, Multicenter, Open-label Safety Study of Bilateral NT-501 in Participants with Macular Telangiectasia Type 2
Participants currently recruited/enrolled
0-125 Years
NEI
000187-EI
Adaptive Optics Imaging of Outer Retinal Diseases
Participants currently recruited/enrolled
0-125 Years
NEI
000108-EI
An Observational Prospective Natural History Study of Stargardt-like Macular Dystrophy (STDG3) Secondary to Mutations in ELOVL4
Recruitment has not started
0-125 Years
NEI
000078-EI
Ocular Findings and Viral Persistence in Ocular Fluids in COVID-19 Survivors, a Natural History, Observational Study
Participants currently recruited/enrolled
18-125 Years
NEI
20-EI-0163
Oral Metformin for Treatment of ABCA4 Retinopathy
Participants currently recruited/enrolled
0-125 Years
NEI
20-EI-0052
A Phase I/IIa Trial for Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated with Age-Related Macular Degeneration
Participants currently recruited/enrolled
55-125 Years
NEI
20-EI-0026
An Observational Cross-Sectional Study of Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease
Participants currently recruited/enrolled
5-125 Years
NEI
20-EI-0004
Adalimumab vs. Conventional Immunosuppression for Uveitis (ADVISE) Trial
Participants currently recruited/enrolled
13-125 Years
NEI
19-EI-0056
A Survey Study of Retinitis Pigmentosa (RP) Clinical Measures and Repeatability Testing of Potential Outcome Measures.
Participants currently recruited/enrolled
12-125 Years
NEI
18-EI-0142
A Phase 2, Randomized, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Filgotinib in Subjects with Active Non-Infectious Uveitis
Completed Study; data analyses ongoing
18-125 Years
NEI
18-EI-0068
An Investigation of Vitamin A Palmitate Supplementation in Patients with Reticular Pseudodrusen (RPD) and Delayed Dark Adaptation
Participants currently recruited/enrolled
50-125 Years
NEI
18-EI-0067
An Investigation of Vitamin A Palmitate Supplementation in Patients with Age-Related Macular Degeneration (and without reticular pseudodrusen) and Delayed Dark Adaptation
Participants currently recruited/enrolled
50-125 Years
NEI
18-EI-0055
A Phase III Multicenter Randomized, Sham Controlled, Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2
No longer recruiting/follow-up only
21-79 Years
NEI
18-EI-0046
Perception, Sensation, Cognition and Action in Humans
Participants currently recruited/enrolled
18-65 Years
NEI
17-EI-0112
A Long-term Follow-up Study of Participants Enrolled in 11-EI-0147: Longitudinal Investigation of Dark Adaptation in Participants with Age-Related Macular Degeneration (DA_AMD)
Participants currently recruited/enrolled
50-125 Years
NEI
17-EI-0071
AMD Ryan Initiative Study
Participants currently recruited/enrolled
55-125 Years
NEI
17-EI-0008
The Natural History of Geographic Atrophy Associated with Age-Related Macular Degeneration
Participants currently recruited/enrolled
0-125 Years
NEI
16-EI-0169
A Pilot Study to Investigate Ustekinumab (STELARA) for the Treatment of Active Sight-Threatening Uveitis
Completed Study; data analyses ongoing
18-125 Years
NEI
16-EI-0159
A Phase I/II Trial for Intravitreous Treatment of Severe Ocular von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist Ranibizumab
Completed Study; data analyses ongoing
18-99 Years
NEI
16-EI-0134
Studies of the Natural History, Pathogenesis and Outcome of Ocular Disorders
Participants currently recruited/enrolled
0-125 Years
NEI
16-EI-0104
Clinical and Molecular Studies in Families with Inherited Eye Disease
Participants currently recruited/enrolled
4-125 Years
NEI
16-EI-0090
Natural History of Spinocerebellar Ataxia Type 7 (SCA7)
Participants currently recruited/enrolled
12-125 Years
NEI
16-EI-0046
Uveitis/Intraocular Inflammatory Disease Biobank (iBank)
Participants currently recruited/enrolled
8-125 Years
NEI
16-EI-0024
Rod and Cone Mediated Function in Retinal Disease
Participants currently recruited/enrolled
5-125 Years
NEI
15-EI-0202
Evaluation of Oral Minocycline in the Treatment of Geographic Atrophy Associated with Age-Related Macular Degeneration
No longer recruiting/follow-up only
0-125 Years
NEI
15-EI-0128
The Genetics of Inherited Eye Disease
Participants currently recruited/enrolled
0-125 Years
NEI
15-EI-0038
A Phase I/IIa Study of RS1 Ocular Gene Transfer for X-linked Retinoschisis
Participants currently recruited/enrolled
18-125 Years
NEI
15-EI-0020
Adaptive Optics Retinal Imaging
Participants currently recruited/enrolled
12-125 Years
NEI
14-EI-0171
The Focal Electro-Oculogram in Macular Disease
Completed Study; data analyses ongoing
10-125 Years
NEI
14-EI-0064
Whole Exome and Whole Genome Sequencing for Genotyping of Inherited and Congenital Eye Conditions
Participants currently recruited/enrolled
0-125 Years
NEI
13-EI-0072
Microbiome and Ocular Inflammatory Disease
Clinical hold/Recruitment or enrollment suspended
18-125 Years
NEI
13-EI-0049
Pathogenesis and Genetics of Microphthalmia, Anophthalmia and Uveal Coloboma ( MAC)
Participants currently recruited/enrolled
1-125 Years
NEI
12-EI-0203
Natural History of ABCA4-Related Retinopathies
No longer recruiting/follow-up only
12-125 Years
NEI
12-EI-0042
NEI Intramural Biorepository for Retinal Diseases
Participants currently recruited/enrolled
2-125 Years
NEI
11-EI-0264
A Pilot Study for the Evaluation of Minocycline as a Microglia Inhibitor in the Treatment of Central Retinal Vein Occlusions
Completed Study; data analyses ongoing
18-125 Years
NEI
11-EI-0263
A Pilot Study for the Evaluation of Minocycline as a Microglia Inhibitor in the Treatment of Branch Retinal Vein Occlusions
Completed Study; data analyses ongoing
18-125 Years
NEI
11-EI-0245
Generation of Induced Pluripotent Stem (iPS) Cell Lines from Somatic Cells of Participants with Eye Diseases and from Somatic Cells of Matched Controls
Participants currently recruited/enrolled
1-125 Years
NEI
11-EI-0147
Longitudinal Investigation of Dark Adaptation in Participants with Age-Related Macular Degeneration
Participants currently recruited/enrolled
50-125 Years
NEI
10-EI-0140
Genotype - phenotype Study of Patients with Plaquenil-induced Retinal Toxicity, with Evaluation of the ABCA4 Gene
Participants currently recruited/enrolled
18-125 Years
NEI
08-EI-0102
Screening Protocol for the Evaluation and Diagnosis of Potential Research Participants
Participants currently recruited/enrolled
2-125 Years
NEI
08-EI-0043
Age-Related Eye Disease Study (AREDS) and AREDS2 Follow-Up
No longer recruiting/follow-up only
50-125 Years
NEI
08-EI-0031
Visual Motor Coordination
Participants currently recruited/enrolled
18-125 Years
NEI
07-EI-0213
LI/NEI Repository
Completed Study; data analyses ongoing
0-125 Years
NEI
06-EI-0236
National Ophthalmic Genotyping and Phenotyping Network Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
No longer recruiting/follow-up only
2-125 Years
NEI
06-EI-0068
The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease
Completed Study; data analyses ongoing
18-125 Years
NEI
03-EI-0033
X-Linked Juvenile Retinoschisis - Clinical and Molecular Studies
Participants currently recruited/enrolled
1-125 Years
NEI